Inventor · disambiguated record
Hongbin Li
Also filed as: LI HONGBIN
23 granted patents·13 pending applications·49 citations·filing 2006–2024
93Inventor score
Files withFORMA THERAPEUTICS INC20ETERNITY BIOSCIENCE INC3GRIFOLS WORLDWIDE OPERATIONS LTD3VALO EARLY DISCOVERY INC3LUNDBECK & CO AS H2
Top patents by PatentIndex Score
36 records- 0194US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 0294US10472342B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2019·4 cites·25 claims
- 0391US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 0490US11814386B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·1 cites·20 claims
- 0590US10457655B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2017·Granted Oct 29, 2019·3 cites·46 claims
- 0690US10399951B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·5 cites·27 claims
- 0787US10450286B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·3 cites·27 claims
- 0886US10995078B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2020·Granted May 4, 2021·1 cites·2 claims
- 0985US8431593B2Heteroaryl amide derivativesHUTCHISON ALAN J·Filed 2007·Granted Apr 30, 2013·13 cites·18 claims
- 1084US11535618B2Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 27, 2022·2 cites·21 claims
- 1183US10889592B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2017·Granted Jan 12, 2021·2 cites·28 claims
- 1282US11524966B1Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2018·Granted Dec 13, 2022·2 cites·15 claims
- 1380US10913753B2Thienopyridine carboxamides as ubiquitin-specific protease inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·2 cites·20 claims
- 1479US10800750B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·20 claims
- 1579US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1678US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 1778US2024132499A1Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1877US2025188079A1Inhibiting cyclic amp-responsive element-binding protein (creb)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1976US2021214323A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2074US12378242B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·19 claims
- 2173US11787803B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·20 claims
- 2268US2025122270A1Intradermal administration of immunoglobulin g preparationGRIFOLS WORLDWIDE OPERATIONS LTD·Filed 2024·Application pending·0 cites
- 2364US2016002188A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2462US12351577B2Inhibiting cyclic AMP-responsive element-binding protein (CREB)FORMA THERAPEUTICS INC·Filed 2020·Granted Jul 8, 2025·0 cites·19 claims
- 2562US11325917B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO HEALTH INC·Filed 2020·Granted May 10, 2022·0 cites·20 claims
- 2661US9133204B25-membered heterocyclic amides and related compoundsLUNDBECK & CO AS H·Filed 2014·Granted Sep 15, 2015·0 cites·13 claims
- 2759US2024001002A1Protein hydrogels and methods for their preparationUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2857US12252490B2Inhibiting deubiquitinase USP25 and USP28VALO HEALTH INC·Filed 2019·Granted Mar 18, 2025·0 cites·15 claims
- 2957US2010292236A15-Membered Heterocyclic Amides And Related CompoundsLUNDBECK & CO AS H·Filed 2008·Application pending·0 cites
- 3056US12091444B2Intradermal administration of immunoglobulin G preparationGRIFOLS WORLDWIDE OPERATIONS LTD·Filed 2020·Granted Sep 17, 2024·0 cites·4 claims
- 3154US2022144842A1Irak inhibitors, preparation method and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 3254US2022177446A1Alkyne compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 3354US2022213086A1Azole compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 3450US12162888B2Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Dec 10, 2024·0 cites·15 claims
- 3543US2007078135A1Substituted heteroaryl CB1 antagonistsNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 3640US2017226191A1Intradermal administration of immunoglobulin g preparationGRIFOLS WORLDWIDE OPERATIONS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hongbin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →